Almujtama Alraida Medical Co.

9592.SRSAUHealthcare● Active

$24.60

+$1.10(+4.68%)

Market Cap$233700000

P/E Ratio—

52W High$33.5

52W Low$22

Avg Volume3K

Open$24.60

Beta0.15

Overview

Almujtama Alraida Medical Co. (9592.SR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

9592.SR · net income · updated Jun 15, 2026

Core profitability metrics

9592.SR · net income · margin · TTM · CAGR

Net income was $8.4M for FY2025 (fiscal year ending 2025-12-31), up 5.9% year-over-year. Net profit margin was 1.9%. Based on available data, Almujtama Alraida Medical Co. has been profitable since at least 2021.

FY2025 Net Income$8.4M▲ +5.9% YoY

Trailing 12M (TTM)$16.3Mtrailing 4 quarters sum

Net Profit Margin1.9%$8.4M ÷ $454.7M

YoY Change+5.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · 9592.SR net income history · 9592.SR profit margin

Annual net income data

9592.SR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$8.4M▲ +5.9%1.9%$454.7M

FY2024$7.9M▼ 30.4%1.8%$430.8M

FY2023$11.4M▼ 40.3%2.8%$407.7M

FY2022$19.1M▲ +144.3%5.2%$367.1M

FY2021★ First Profit$7.8M—2.6%$304.5M

Net income vs peers (Healthcare)

9592.SR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Almujtama Alraida Medical Co.YOU

9592.SR

$8.4M+5.9%1.9%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Almujtama Alraida Medical Co. (9592.SR) reported net income of $8.4M for FY2025 (fiscal year ending 2025-12-31), up 5.9% year-over-year. The net profit margin was 1.9% — meaning the company kept $0.02 of every dollar of revenue as profit.

Based on available data, Almujtama Alraida Medical Co. has been profitable since at least 2021. Net income reached a peak of $19.1M in FY2022. Data available for 5 fiscal years.

Almujtama Alraida Medical Co.'s net profit margin was 1.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Almujtama Alraida Medical Co. net worth" — the company's market capitalization is a separate figure from 9592.SR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

9592.SR net income · 5 questions

Almujtama Alraida Medical Co. is profitable. The company reported net income of $8.4M for FY2025, a net profit margin of 1.9%. Net income was up 5.9% year-over-year. Based on available data, Almujtama Alraida Medical Co. has been profitable since at least 2021.

is 9592.SR profitabledoes 9592.SR make a profit9592.SR profitability9592.SR profitable company

▸ Source: FMP /income-statement · GAAP · Almujtama Alraida Medical Co. · Almujtama Alraida Medical Co. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026